<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kassem AF</submitter><funding>Deanship of Scientific Research, Princess Nourah Bint Abdulrahman University</funding><pagination>1033-1048</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11726445</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>15(2)</volume><pubmed_abstract>A novel molecular design based on a quinazolinone scaffold was developed &lt;i>via&lt;/i> the attachment of aryl alkanesulfonates to the quinazolinone core through a thioacetohydrazide azomethine linker, leading to a new series of quinazolinone-alkanesulfonates 5a-r. The antimicrobial properties of the newly synthesized quinazolinone derivatives 5a-r were investigated to examine their bactericidal and fungicidal activities against bacterial pathogens like &lt;i>Bacillus subtilis&lt;/i>, &lt;i>Staphylococcus aureus&lt;/i> (Gram-positive), &lt;i>Pseudomonas aeruginosa&lt;/i>, &lt;i>Klebsiella pneumonia&lt;/i>, &lt;i>Sallmonella Typhimurium&lt;/i> (Gram-negative), in addition to &lt;i>Candida albicans&lt;/i> (unicellular fungal). The tested compounds demonstrated reasonable bactericidal activities compared to standard drugs. Notably,</pubmed_abstract><journal>RSC advances</journal><pubmed_title>New quinazolone-sulfonate conjugates with an acetohydrazide linker as potential antimicrobial agents: design, synthesis and molecular docking simulations.</pubmed_title><pmcid>PMC11726445</pmcid><funding_grant_id>PNURSP2024R89</funding_grant_id><pubmed_authors>Omar MA</pubmed_authors><pubmed_authors>Temirak A</pubmed_authors><pubmed_authors>Ragab SS</pubmed_authors><pubmed_authors>Altwaijry NA</pubmed_authors><pubmed_authors>Abdelraof M</pubmed_authors><pubmed_authors>Srour AM</pubmed_authors><pubmed_authors>Kassem AF</pubmed_authors><pubmed_authors>Saleh A</pubmed_authors></additional><is_claimable>false</is_claimable><name>New quinazolone-sulfonate conjugates with an acetohydrazide linker as potential antimicrobial agents: design, synthesis and molecular docking simulations.</name><description>A novel molecular design based on a quinazolinone scaffold was developed &lt;i>via&lt;/i> the attachment of aryl alkanesulfonates to the quinazolinone core through a thioacetohydrazide azomethine linker, leading to a new series of quinazolinone-alkanesulfonates 5a-r. The antimicrobial properties of the newly synthesized quinazolinone derivatives 5a-r were investigated to examine their bactericidal and fungicidal activities against bacterial pathogens like &lt;i>Bacillus subtilis&lt;/i>, &lt;i>Staphylococcus aureus&lt;/i> (Gram-positive), &lt;i>Pseudomonas aeruginosa&lt;/i>, &lt;i>Klebsiella pneumonia&lt;/i>, &lt;i>Sallmonella Typhimurium&lt;/i> (Gram-negative), in addition to &lt;i>Candida albicans&lt;/i> (unicellular fungal). The tested compounds demonstrated reasonable bactericidal activities compared to standard drugs. Notably,</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jan</publication><modification>2026-06-02T07:05:08.305Z</modification><creation>2025-04-19T14:06:16.609Z</creation></dates><accession>S-EPMC11726445</accession><cross_references><pubmed>39807202</pubmed><doi>10.1039/d4ra07563c</doi></cross_references></HashMap>